Category Archives: News

‘I know of nothing that is more bipartisan’ than curing cancer, Biden says during joint address

President Joe Biden said that ending cancer was a bipartisan issue during his joint address to Congress on Wednesday. “I can think of no more worthy investment. I know of nothing that is more bipartisan,” Biden said. “So let’s end cancer as we know it. It’s within our power to do it.” BIDEN STRIKES OPTIMISTIC… Read More »

HHS announces additional staff appointees

Photo by Stefani Reynolds/Getty Images The Department of Health and Human Services today announced its latest round of appointments under the Biden Administration. These new appointees join the department at a time when their expertise is needed to end the ongoing COVID-19 pandemic, implement President Biden’s American Rescue Plan and restore public trust in the… Read More »

Joe Rogan tells 21-year-olds not to get COVID vaccine on popular Spotify show

When it comes to healthy, younger people, Joe Rogan says getting a COVID-19 vaccine isn’t even worth a shot — despite advice from the CDC and medical experts saying otherwise. Rogan made the claim on the April 23 edition of his highly popular Spotify podcast, “The Joe Rogan Experience,” according to Media Matters. “If you’re,… Read More »

Royal Caribbean halts hiring in India, suspends Indian crew assignments as Covid cases surge

The Mariner of the Seas cruise ship, operated by Royal Caribbean Cruises Ltd., shown in 2018. Bloomberg | Bloomberg | Getty Images Royal Caribbean Cruises is temporarily suspending all assignments for its staff from India and will halt hiring in the country, amid a surge of Covid-19 cases there, according to a report by Crew… Read More »

FDA Approves Jemperli (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer

FDA Approves Jemperli (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer London UK 22 April 2021 — GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody, based on the company’s Biologics License Application. Jemperli is indicated for the treatment of adult… Read More »